Intestinal absorption of berberine and 8-hydroxy dihydroberberine and their effects on sugar absorption in rat small intestine

Abstract

The intestinal absorption of berberine (Ber) and its structural modified compound 8-hydroxy dihydroberberine (Hdber) was compared, and their effects on the intestinal absorption of sugar by perfusion experiment were investigated in order to reveal the mechanism of low dose and high activity of Hdber in the treatment of hyperglycemia. The absorption of Hdber and Ber in rat small intestine was measured by in situ perfusion. High performance liquid chromatography (HPLC) was used to determine the concentrations of Hdber and Ber. In situ perfusion method was also used to study the effects of Hdber and Ber on sugar intestinal absorption. Glucose oxidase method and UV spectrophotometry were applied to examine the concentrations of glucose and sucrose in the perfusion fluid. The results showed that the absorption rate of Ber in the small intestine was lower than 10%, but that of Hdber was larger than 70%. Both Hdber and Ber inhibited the absorption of glucose and sucrose at the doses of 10 and 20 μg/mL. However, Hdber presented stronger activity than Ber (P<0.01). It is suggested that Hdber is absorbed easily in rat small intestine and that its inhibitory effect on the absorption of sugar is better than Ber.

Keywords

berberine / 8-hydroxy dihydroberberine / perfusion / absorption / high performance liquid chromatography / sugar

References

[1] YinJ, ZhangH, YeJ. Traditional Chinese medicine in treatment of metabolic syndrome. Endocr Metab Immune Disord Drug Targets, 2008, 8(2): 99-111

[2] LauCW, YaoXQ, ChenZY, et al.. Cardiovascular actions of berberine. Cardiovasc Drug Rev, 2001, 19(3): 234-244

[3] SackRB, FroehlichJL. Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins. Infect Immun, 1982, 35(2): 471-475

[4] ChengZ, PangT, GuM, et al.. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. Biochim Biophys Acta, 2006, 1760(11): 1682-1689

[5] FaikP, MorganM, NaftalinRJ, et al.. Transport and accumulation of 2-deoxy-D-glucose in wild-type and hexokinase-deficient cultured Chinese-hamster ovary (CHO) cells. Biochem J, 1989, 260(1): 153-155

[6] GaoZ, ChiaoP, ZhangX, et al.. Coactivators and corepressors of NF-kappaB in IkappaB alpha gene promoter. J Biol Chem, 2005, 280(22): 21 091-21 098

[7] GaoZ, ZhangX, ZuberiA, et al.. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol Endocrinol, 2004, 18(8): 2024-2034

[8] YinJ, XingHL, YeJP. Efficacy of berberine in patients with type 2 diabetes. Metabolism, 2008, 57(5): 712-717

[9] ZhangY, LiX, ZouD, et al.. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab, 2008, 93(7): 2559-2565

[10] LeeYS, KimWS, KimKH, et al.. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes, 2006, 55(8): 2256-2264

[11] KongWJ, ZhangH, SongDQ, et al.. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism, 2009, 58(1): 109-119

[12] ZhangH, WeiJ, XueR, et al.. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism, 2010, 59(2): 285-292

[13] LiGS, LiuXH, ZhuH, et al.. Berberine-improved visceral white adipose tissue insulin resistance associated with altered sterol regulatory element-binding proteins, liver x receptors, and peroxisome proliferator-activated receptors transcriptional programs in diabetic hamsters. Biol Pharm Bull, 2011, 34(5): 644-654

[14] YinJ, HuR, ChenM, et al.. Effects of berberine on glucose metabolism in vitro. Metabolism, 2002, 51(11): 1439-1443

[15] GuY, ZhangY, ShiX, et al.. Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabolomics. Talanta, 2010, 81(3): 766-772

[16] LiuL, YuYL, YangJS, et al.. Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study. Naunyn Schmiedebergs Arch Pharmacol, 2010, 381(4): 371-381

[17] PanGY, HuangZJ, WangGJ, et al.. The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. Planta Med, 2003, 69(7): 632-636

[18] ChenW, FanD, MengL, et al.. Enhancing effects of chitosan and chitosan hydrochloride on intestinal absorption of berberine in rats. Drug Dev Ind Pharm, 2012, 38(1): 104-110

[19] PanGY, WangGJ, LiuXD, et al.. The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol, 2002, 91(4): 193-197

[20] XuLJ, LuFE, WeiSC. Comparison of therapeutic effects between 8-hydroxy dihydroberberine and berberine hydrochlorde on ype 2 diabetes mellitus in rats. Zhong Xi Yi Jie He Yan Jiu (Chinese), 2009, 1(4): 173-176

[21] XuLJ, LuFE, WeiSC. Effects on improving 3T3-L1 lipocyte insulin resistance induced by high FFA and high glucose of 8-Hydroxydihydroberberine. Yao Xue Xue Bao (Chinese), 2009, 11(44): 1304-1308

[22] LvXY, LiJ, ZhangM, et al.. Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine. AAPS Pharm Sci Tech, 2010, 11(1): 372-382

[23] LeeTS, PanCC, PengCC, et al.. Anti-atherogenic effect of berberine on LXRalpha-ABCA1-dependent cholesterol efflux in macrophages. J Cell Biochem, 2010, 111(1): 104-110

[24] ZengXH, ZengXJ, LiYY. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol, 2003, 92(2): 173-176

[25] PanGY, WangGJ, SunJG, et al.. Inhibitory action of berberine on glucose absorption. Yao Xue Xue Bao (Chinese), 2003, 38(12): 911-914